← Back to Search

Other

Precision pharmacotherapy for Smoking Cessation

N/A
Waitlist Available
Led By Scott D Siegel, Ph.D.
Research Sponsored by Christiana Care Health Services
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-week follow-up
Awards & highlights

Study Summary

This trial will help researchers understand if recommending a specific medication to smokers, based on how quickly they metabolize nicotine, will help them quit smoking.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-week follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-week follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants Who Achieve Smoking Cessation
Secondary outcome measures
Percentage of Participants Who Reported Use of a Smoking Medication That Matched Their NMR Profile
Percentage of Participants Who Reported Using Smoking Cessation Medication (1-week)
Percentage of Participants Who Reported Using Smoking Cessation Medication (4-week)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment Plan Option 2 (Precision Pharmacotherapy)Experimental Treatment1 Intervention
Standard smoking cessation counseling will be offered + a recommendation to take either the nicotine patch or varenicline based on the results of the NMR test. Regardless of the recommendation, it would still remain the participant's choice to be prescribed either nicotine patches or varenicline. Participants are also free to decline either medication.
Group II: Treatment Plan Option 1 (Standard Care)Active Control1 Intervention
Standard smoking cessation counseling will be offered + participant choice of nicotine patches or varenicline. Participants are also free to decline either medication.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Precision pharmacotherapy
2022
N/A
~40

Find a Location

Who is running the clinical trial?

Christiana Care Health ServicesLead Sponsor
114 Previous Clinical Trials
105,614 Total Patients Enrolled
University of DelawareOTHER
154 Previous Clinical Trials
25,174 Total Patients Enrolled
National Institute of General Medical Sciences (NIGMS)NIH
268 Previous Clinical Trials
248,723 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are allowed to join this research project?

"Affirmative. Clinicaltrials.gov records indicate that this trial, which was uploaded on February 23rd 2022, is actively recruiting patients for its research. Up to 100 participants can register from 1 clinical site."

Answered by AI

Are participants still being accepted for this experiment?

"Affirmative. Clinicaltrials.gov reveals that this clinical research is still searching for participants, the trial began on February 23rd 2022 and was recently updated on May 23rd of the same year; they seek to enroll 100 volunteers across a single medical center."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Precision Pharmacotherapy Smoking Cessation Program
Scott Siegel 2022. "Precision Pharmacotherapy Smoking Cessation Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04897607.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top